Results
|
8561.
|
|
|
8562.
|
|
|
8563.
|
|
|
8564.
|
|
|
8565.
|
|
|
8566.
|
|
|
8567.
|
|
|
8568.
|
|
|
8569.
|
|
|
8570.
|
|
|
8571.
|
|
|
8572.
|
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. [electronic resource] by
- Ockenhouse, C F
- Sun, P F
- Lanar, D E
- Wellde, B T
- Hall, B T
- Kester, K
- Stoute, J A
- Magill, A
- Krzych, U
- Farley, L
- Wirtz, R A
- Sadoff, J C
- Kaslow, D C
- Kumar, S
- Church, L W
- Crutcher, J M
- Wizel, B
- Hoffman, S
- Lalvani, A
- Hill, A V
- Tine, J A
- Guito, K P
- de Taisne, C
- Anders, R
- Ballou, W R
Producer: 19980618
In:
The Journal of infectious diseases vol. 177
Availability: No items available.
|
|
8573.
|
|
|
8574.
|
|
|
8575.
|
|
|
8576.
|
|
|
8577.
|
|
|
8578.
|
|
|
8579.
|
|
|
8580.
|
|